Nonviral pulmonary delivery of siRNA

Accounts of Chemical Research

Volumn 45, Issue 7, 2012, Pages 961-970

  Merkel, Olivia M ^a   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LIPID; POLYMER; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ADMINISTRATION ROUTE; GENETIC TRANSFECTION; GENETICS; LUNG; METABOLISM; MOUSE; RNA INTERFERENCE; TISSUE DISTRIBUTION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; GREEN FLUORESCENT PROTEINS; LIPIDS; LUNG; MICE; POLYMERS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 84863928267     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar200110p     Document Type: Article

References (69)

1. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 1998, 391, 806-811
2. Hammond, S. M.; Boettcher, S.; Caudy, A. A.; Kobayashi, R.; Hannon, G. J. Argonaute2, a link between genetic and biochemical analyses of RNAi Science 2001, 293, 1146-1150
3. Katiyar-Agarwal, S.; Morgan, R.; Dahlbeck, D.; Borsani, O.; Villegas, A., Jr.; Zhu, J. K.; Staskawicz, B. J.; Jin, H. A pathogen-inducible endogenous siRNA in plant immunity Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 18002-18007
4. Agrawal, N.; Dasaradhi, P. V.; Mohmmed, A.; Malhotra, P.; Bhatnagar, R. K.; Mukherjee, S. K. RNA interference: biology, mechanism, and applications Microbiol. Mol. Biol. Rev. 2003, 67, 657-685
5. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001, 411, 494-498
6. Dorsett, Y.; Tuschl, T. siRNAs: applications in functional genomics and potential as therapeutics Nat. Rev. Drug Discovery 2004, 3, 318-329
7. Watts, J. K.; Corey, D. R. Clinical status of duplex RNA Bioorg. Med. Chem. Lett. 2010, 20, 3203-3207
8. Dykxhoorn, D. M.; Lieberman, J. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs Annu. Rev. Biomed. Eng. 2006, 8, 377-402
9. Durcan, N.; Murphy, C.; Cryan, S. A. Inhalable siRNA: potential as a therapeutic agent in the lungs Mol. Pharmaceutics 2008, 5, 559-666
10. de Fougerolles, A.; Novobrantseva, T. siRNA and the lung: research tool or therapeutic drug? Curr. Opin. Pharmacol. 2008, 8, 280-285
11. World Health Organization. No. 310; F. s., Ed.; World Health Organization: New York, 2008.
12. Birchall, J. Pulmonary delivery of nucleic acids Expert Opin. Drug Delivery 2007, 4, 575-578
13. Cryan, S. A.; Sivadas, N.; Garcia-Contreras, L. In vivo animal models for drug delivery across the lung mucosal barrier Adv. Drug Delivery Rev. 2007, 59, 1133-1151
14. Akhtar, S.; Benter, I. F. Nonviral delivery of synthetic siRNAs in vivo J. Clin. Invest. 2007, 117, 3623-3632
15. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 2005, 113, 823-839
16. Sanders, N.; Rudolph, C.; Braeckmans, K.; De Smedt, S. C.; Demeester, J. Extracellular barriers in respiratory gene therapy Adv. Drug Delivery Rev. 2009, 61, 115-127
17. Dames, P.; Gleich, B.; Flemmer, A.; Hajek, K.; Seidl, N.; Wiekhorst, F.; Eberbeck, D.; Bittmann, I.; Bergemann, C.; Weyh, T.; Trahms, L.; Rosenecker, J.; Rudolph, C. Targeted delivery of magnetic aerosol droplets to the lung Nat. Nanotechnol. 2007, 2, 495-499
18. Jiang, H. L.; Xu, C. X.; Kim, Y. K.; Arote, R.; Jere, D.; Lim, H. T.; Cho, M. H.; Cho, C. S. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway Biomaterials 2009, 30, 5844-5852
19. Braasch, D. A.; Paroo, Z.; Constantinescu, A.; Ren, G.; Oz, O. K.; Mason, R. P.; Corey, D. R. Biodistribution of phosphodiester and phosphorothioate siRNA Bioorg. Med. Chem. Lett. 2004, 14, 1139-1143
20. Bitko, V.; Musiyenko, A.; Shulyayeva, O.; Barik, S. Inhibition of respiratory viruses by nasally administered siRNA Nat. Med. 2005, 11, 50-55
21. Lomas-Neira, J. L.; Chung, C. S.; Wesche, D. E.; Perl, M.; Ayala, A. In vivo gene silencing(with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury J. Leukocyte Biol. 2005, 77, 846-853
22. Perl, M.; Chung, C. S.; Lomas-Neira, J.; Rachel, T. M.; Biffl, W. L.; Cioffi, W. G.; Ayala, A. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis Am. J. Pathol. 2005, 167, 1545-1559
23. Rosas-Taraco, A. G.; Higgins, D. M.; Sanchez-Campillo, J.; Lee, E. J.; Orme, I. M.; Gonzalez-Juarrero, M. Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis Am. J. Respir. Cell Mol. Biol. 2009, 41, 136-145
24. Li, B. J.; Tang, Q.; Cheng, D.; Qin, C.; Xie, F. Y.; Wei, Q.; Xu, J.; Liu, Y.; Zheng, B. J.; Woodle, M. C.; Zhong, N.; Lu, P. Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque Nat. Med. 2005, 11, 944-951
25. Zhang, X.; Shan, P.; Jiang, D.; Noble, P. W.; Abraham, N. G.; Kappas, A.; Lee, P. J. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis J. Biol. Chem. 2004, 279, 10677-10684
26. Kim, T. H.; Kim, S. H.; Seo, J. Y.; Chung, H.; Kwak, H. J.; Lee, S. K.; Yoon, H. J.; Shin, D. H.; Park, S. S.; Sohn, J. W. Blockade of the Wnt/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis Tohoku J. Exp. Med. 2011, 223, 45-54
27. Rosas-Taraco, A. G.; Higgins, D. M.; Sanchez-Campillo, J.; Lee, E. J.; Orme, I. M.; Gonzalez-Juarrero, M. Local pulmonary immunotherapy with siRNA targeting TGFbeta1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice Tuberculosis (Oxford, U.K.) 2010, 91, 98-106
28. Senoo, T.; Hattori, N.; Tanimoto, T.; Furonaka, M.; Ishikawa, N.; Fujitaka, K.; Haruta, Y.; Murai, H.; Yokoyama, A.; Kohno, N. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis Thorax 2010, 65, 334-340
29. Cho, H. Y.; Gladwell, W.; Wang, X.; Chorley, B.; Bell, D.; Reddy, S. P.; Kleeberger, S. R. Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice Am. J. Respir. Crit. Care Med. 2010, 182, 170-182
30. Kleemann, E.; Neu, M.; Jekel, N.; Fink, L.; Schmehl, T.; Gessler, T.; Seeger, W.; Kissel, T. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI J. Controlled Release 2005, 109, 299-316
31. Ge, Q.; Filip, L.; Bai, A.; Nguyen, T.; Eisen, H. N.; Chen, J. Inhibition of influenza virus production in virus-infected mice by RNA interference Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 8676-8681
32. Robbins, M.; Judge, A.; Ambegia, E.; Choi, C.; Yaworski, E.; Palmer, L.; McClintock, K.; MacLachlan, I. Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation Hum. Gene Ther. 2008, 19, 991-999
33. Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D. W. Y. RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2006, 2, 711-719
34. Sioud, M.; Furset, G.; Cekaite, L. Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs Biochem. Biophys. Res. Commun. 2007, 361, 122-126
35. Kim, D. H.; Behlke, M. A.; Rose, S. D.; Chang, M. S.; Choi, S.; Rossi, J. J. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy Nat. Biotechnol. 2005, 23, 222-226
36. Merkel, O. M.; Beyerle, A.; Librizzi, D.; Pfestroff, A.; Behr, T. M.; Sproat, B.; Barth, P. J.; Kissel, T. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance Mol. Pharmaceutics 2009, 6, 1246-1260
37. Glud, S. Z.; Bramsen, J. B.; Dagnaes-Hansen, F.; Wengel, J.; Howard, K. A.; Nyengaard, J. R.; Kjems, J. Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration Oligonucleotides 2009, 19, 163-168
38. Li, T.; Folkesson, H. G. RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290, L649-L660
39. Zhang, W.; Yang, H.; Kong, X.; Mohapatra, S.; San Juan-Vergara, H.; Hellermann, G.; Behera, S.; Singam, R.; Lockey, R. F.; Mohapatra, S. S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene Nat. Med. 2005, 11, 56-62
40. Zamora-Avila, D. E.; Zapata-Benavides, P.; Franco-Molina, M. A.; Saavedra-Alonso, S.; Trejo-Avila, L. M.; Resendez-Perez, D.; Mendez-Vazquez, J. L.; Isaias-Badillo, J.; Rodriguez-Padilla, C. WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth Cancer Gene Ther. 2009, 16, 892-899
41. Tompkins, S. M.; Lo, C. Y.; Tumpey, T. M.; Epstein, S. L. Protection against lethal influenza virus challenge by RNA interference in vivo Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 8682-8686
42. Griesenbach, U.; Kitson, C.; Escudero Garcia, S.; Farley, R.; Singh, C.; Somerton, L.; Painter, H.; Smith, R. L.; Gill, D. R.; Hyde, S. C.; Chow, Y. H.; Hu, J.; Gray, M.; Edbrooke, M.; Ogilvie, V.; MacGregor, G.; Scheule, R. K.; Cheng, S. H.; Caplen, N. J.; Alton, E. W. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo Respir. Res. 2006, 7, 26
43. Garbuzenko, O. B.; Saad, M.; Betigeri, S.; Zhang, M.; Vetcher, A. A.; Soldatenkov, V. A.; Reimer, D. C.; Pozharov, V. P.; Minko, T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug Pharm. Res. 2009, 26, 382-394
44. Maurer, N.; Fenske, D. B.; Cullis, P. R. Developments in liposomal drug delivery systems Expert Opin. Biol. Ther. 2001, 1, 923-947
45. Li, X.; Molina-Molina, M.; Abdul-Hafez, A.; Uhal, V.; Xaubet, A.; Uhal, B. D. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295, L178-L185
46. Kong, X.; Zhang, W.; Lockey, R. F.; Auais, A.; Piedimonte, G.; Mohapatra, S. S. Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene Genet. Vaccines Ther. 2007, 5, 4
47. Howard, K. A.; Rahbek, U. L.; Liu, X.; Damgaard, C. K.; Glud, S. Z.; Andersen, M. O.; Hovgaard, M. B.; Schmitz, A.; Nyengaard, J. R.; Besenbacher, F.; Kjems, J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system Mol. Ther. 2006, 14, 476-484
48. Nielsen, E. J.; Nielsen, J. M.; Becker, D.; Karlas, A.; Prakash, H.; Glud, S. Z.; Merrison, J.; Besenbacher, F.; Meyer, T. F.; Kjems, J.; Howard, K. A. Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles Pharm. Res. 2010, 27, 2520-2527
49. Kamlah, F.; Eul, B. G.; Li, S.; Lang, N.; Marsh, L. M.; Seeger, W.; Grimminger, F.; Rose, F.; Hanze, J. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model Cancer Gene Ther. 2009, 16, 195-205
50. Thomas, M.; Lu, J. J.; Ge, Q.; Zhang, C.; Chen, J.; Klibanov, A. M. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5679-5684
51. Beyerle, A.; Braun, A.; Merkel, O.; Koch, F.; Kissel, T.; Stoeger, T. Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice J. Controlled Release 2011, 151, 51-56
52. Merkel, O. M.; Beyerle, A.; Beckmann, B. M.; Zheng, M.; Hartmann, R. K.; Stoger, T.; Kissel, T. H. Polymer-related off-target effects in non-viral siRNA delivery Biomaterials 2011, 32, 2388-2398
53. Merkel, O. M.; Urbanics, R.; Bedocs, P.; Rozsnyay, Z.; Rosivall, L.; Toth, M.; Kissel, T.; Szebeni, J. In vitro and in vivo Complement Activation and Related Anaphylactic Effects Associated with Polyethylenimine and Polyethylenimine- graft -poly(ethylene glycol) Block Copolymers Biomaterials 2011, 32, 4936-4942
54. Dailey, L. A.; Jekel, N.; Fink, L.; Gessler, T.; Schmehl, T.; Wittmar, M.; Kissel, T.; Seeger, W. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung Toxicol. Appl. Pharmacol. 2006, 215, 100-108
55. Nguyen, J.; Steele, T. W.; Merkel, O.; Reul, R.; Kissel, T. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy J. Controlled Release 2008, 132, 243-251
56. Ming, X. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis Expert Opin. Drug Delivery 2011, 8, 435-449
57. Moschos, S. A.; Jones, S. W.; Perry, M. M.; Williams, A. E.; Erjefalt, J. S.; Turner, J. J.; Barnes, P. J.; Sproat, B. S.; Gait, M. J.; Lindsay, M. A. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity Bioconjugate Chem. 2007, 18, 1450-1459
58. Zhang, W.; Tripp, R. A. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response J. Virol. 2008, 82, 12221-12231
59. Kwok, T.; Helfer, H.; Alam, M. I.; Heinrich, J.; Pavlovic, J.; Moelling, K. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides Arch. Virol. 2009, 154, 109-114
60. Perl, M.; Chung, C. S.; Perl, U.; Thakkar, R.; Lomas-Neira, J.; Ayala, A. Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury Crit. Care Med. 2010, 38, 1179-1186
61. Huang, H. Y.; Lee, C. C.; Chiang, B. L. Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness Gene Ther. 2008, 15, 660-667
62. Wang, X.; Xu, W.; Mohapatra, S.; Kong, X.; Li, X.; Lockey, R. F.; Mohapatra, S. S. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor Genet. Vaccines Ther. 2008, 6, 7
63. Wang, J. C.; Lai, S.; Guo, X.; Zhang, X.; de Crombrugghe, B.; Sonnylal, S.; Arnett, F. C.; Zhou, X. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA Arthritis Res. Ther. 2010, 12, R60
64. Gutbier, B.; Kube, S. M.; Reppe, K.; Santel, A.; Lange, C.; Kaufmann, J.; Suttorp, N.; Witzenrath, M. RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice Pulm. Pharmacol. Ther. 2010, 23, 334-344
65. Massaro, D.; Massaro, G. D.; Clerch, L. B. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287, L1066-L1070
66. Birchall, J. C.; Kellaway, I. W.; Gumbleton, M. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes Int. J. Pharm. 2000, 197, 221-231
67. Kasper, J. C.; Schaffert, D.; Ogris, M.; Wagner, E.; Friess, W. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability-A step closer from promising technology to application J. Controlled Release 2011, 151, 246-255
68. Beek, E. J. R. v.; Wild, J. M.; Kauczor, H.-U.; Schreiber, W., III; M., J. P.; Lange, E. E. d. Functional MRI of the lung using hyperpolarized 3-helium gas J. Magn. Reson. Imaging 2004, 20, 540-554
69. Merkel, O. M.; Librizzi, D.; Pfestroff, A.; Schurrat, T.; Behe, M.; Kissel, T. In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure Bioconjugate Chem. 2009, 20, 174-182